SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001575872-23-000178
Filing Date
2023-01-30
Accepted
2023-01-30 16:01:29
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A lb079_s1a.htm S-1/A 2148807
2 EXHIBIT 1.1 lb079_ex1-1.htm EX-1.1 218381
3 EXHIBIT 10.16 lb079_ex10-16.htm EX-10.16 37289
4 EXHIBIT 10.17 lb079_ex10-17.htm EX-10.17 137326
5 EXHIBIT 10.18 lb079_ex10-18.htm EX-10.18 89029
6 EXHIBIT 10.19 lb079_ex10-19.htm EX-10.19 85709
7 EXHIBIT 23.1 lb079_ex23-1.htm EX-23.1 6046
8 EX-FILING FEES lb079_ex107.htm EX-FILING FEES 44680
9 GRAPHIC lb079_s1img01.jpg GRAPHIC 13391
10 GRAPHIC lb079_s1img02.jpg GRAPHIC 56914
11 GRAPHIC lb079_s1img03.jpg GRAPHIC 103235
12 GRAPHIC lb079_s1img04.jpg GRAPHIC 265307
13 GRAPHIC lb079_s1img05.jpg GRAPHIC 138395
14 GRAPHIC lb079_s1img06.jpg GRAPHIC 20885
15 GRAPHIC lb079_ex23-1img01.jpg GRAPHIC 20885
  Complete submission text file 0001575872-23-000178.txt   3621927
Mailing Address 2054 VISTA PARKWAY SUITE 400 WEST PALM BEACH FL 33411
Business Address 2054 VISTA PARKWAY SUITE 400 WEST PALM BEACH FL 33411 844-321-6362
MDNA Life Sciences, Inc. (Filer) CIK: 0001645108 (see all company filings)

IRS No.: 300845609 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-1/A | Act: 33 | File No.: 333-266613 | Film No.: 23567647
SIC: 2835 In Vitro & In Vivo Diagnostic Substances